Metabolic profiling of organic and fatty acids in chronic and autoimmune diseases

Adv Clin Chem. 2021:101:169-229. doi: 10.1016/bs.acc.2020.06.003. Epub 2020 Jul 15.

Abstract

Metabolomics is a powerful tool of omics that permits the simultaneous identification of metabolic perturbations in several autoimmune and chronic diseases. Several parameters can affect a metabolic profile, from the population characteristics to the selection of the analytical method. In the current chapter, we summarize the main analytical methods and results of the metabolic profiling of fatty and organic acids performed in human metabolomic studies for asthma, COPD, psoriasis and Hashimoto's thyroiditis. We discuss the most significant metabolic alterations associated with these diseases, after comparison of either a single patient's group with healthy controls or several patient's subgroups of different disease severity and phenotype with healthy controls or of a patient's group before and after treatment. Finally, we present critical metabolic patterns that are associated with each disease and their potency for the unraveling of disease pathogenesis, prediction, diagnosis, patient stratification and treatment selection.

Keywords: Asthma; Biomarkers; COPD; Fatty acids; Hashimoto's thyroiditis; Metabolic profiling; Metabolomics; Organic acids; Psoriasis; Treatment selection.

MeSH terms

  • Asthma / metabolism
  • Autoimmune Diseases / metabolism*
  • Chronic Disease
  • Fatty Acids / metabolism*
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Metabolome
  • Pulmonary Disease, Chronic Obstructive / metabolism

Substances

  • Fatty Acids